Significant Ownership of SCOTT D. SANDELL

Location
Timonium, MD
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by SCOTT D. SANDELL.

Notify me when SCOTT D. SANDELL files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of SCOTT D. SANDELL

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ACLX Arcellx, Inc. Common Stock $0.001 par value per share 5.5% $200,278,848 -$45,223,076 3,055,360 -18% Scott D. Sandell 12 Aug 2025
VRNA Verona Pharma plc Ordinary Shares, nominal value 0.05 GBP 5% $2,139,209,824 32,679,649 Scott D. Sandell 16 Jan 2025

Schedules 13D/G Reported by SCOTT D. SANDELL:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.